期刊文献+

替罗非班治疗老年冠心病的临床研究

Clinical Research of tirofiban in the Treatment of Senile Coronary Heart Disease
原文传递
导出
摘要 目的:探讨替罗非班治疗老年冠心病的疗效. 方法:自2012年2月~2014年8月,我院应用替罗非班治疗老年冠心病患者98例,按照完全随机法将患者随机分为2组,即实验组和对照组,每组49例,2组患者均在一般治疗的基础上,实验组应用替罗非班治疗,对照组应用阿司匹林和氯吡格雷治疗. 治疗结束后观察2 组患者的疗效以及不良反应. 结果:实验组痊愈36例,有效12例,总有效率97. 96%,对照组痊愈31例,有效11例,总有效率85. 71%,2组相比差异明显(p〈0. 05). 结论:替罗非班治疗老年冠心病有效,安全. Objective:To investigate the curative effect of tirofiban in treatment of senile coronary heart disease. Methods:from 2012 February to 2014 August in our hospital, the application of tirofiban in the treatment of 98 cases of elderly patients with coronary heart dis-ease, according to completely randomized patients were randomly divided into two groups, namely experimental group and control group, 49 cases in each group, the two groups of patients on the basis of routine treatment, the experimental group application of tirofiban treat-ment, the control group use of aspirin and clopidogrel therapy. Observation of the curative effect and adverse reaction of two groups of pa-tients after treatment. Results:the experimental group 36 cases were cured, effective in 12 cases, the total efficiency of 97. 96%, control group 31 cases were cured, effective in 11 cases, the total efficiency of 85. 71%, difference between the two groups was significantly (p〈0. 05). Conclusion:the treatment of tirofiban in elderly patients with coronary heart disease effectively, safety.
作者 王春蕾 张丹
出处 《中国伤残医学》 2015年第21期14-15,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 老年 冠心病 替罗非班 The elderly Coronary heart disease Tirofiban
  • 相关文献

参考文献4

二级参考文献32

  • 1孙菁,沈洪.急性心肌梗死患者冠状动脉再通后无复流相关因素的分析[J].中国全科医学,2009,12(7):551-553. 被引量:20
  • 2肖丽,王欣.盐酸替罗非班致血小板减少[J].药物不良反应杂志,2006,8(4):292-292. 被引量:7
  • 3余可斐,雷枫琴,杨睿.盐酸替罗非班用于PCI术后冠心病患者的护理[J].郧阳医学院学报,2007,26(3):185-186. 被引量:3
  • 4Stone GW,Grines CL,Cox DA,et al.Comparision of angioplasty with stenting,with or without abciximab,in acute myocardial infarction[J].N Eng J Med,2002,346:957-966.
  • 5Brener SJ,Barr LA,Burchenal JE,et al.Randomized,placebo-controlled trial of platelet glycoprotein Ⅱb /Ⅲa blockade with primary angioplasty for acute myocardial infarction.ReoPro and Primary PTCA Organization and Randomized Trial(RAPPORT) Investigators[J].Circulation,1998,98(8):734-741.
  • 6Montalescot G,Barragan P,Wittenbery O,et al.Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction[J].N Eng J Med,2001,21:1895-1903.
  • 7Martínez-Ríos MA,Rosas M,González H,et al.Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction[J].Am J Cardiol,2004,93(3):280-287.
  • 8Dong J,Ndrepepa G,Schmitt C,et al.Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99 msestamibiscintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy[J].Circulation,2002,105:2946-2949.
  • 9Mega JL,Morrow DA,De Lemos JA.B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction:an ENTIRE-TIMI-23 substudy[J].J Am Coll Cardiol,2004,44(2):335-339.
  • 10Labinaz M,Ho C,Banerjee S,et al.Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein Ⅱb/Ⅲa an tagonists for percutaneous coronary intervention[J].Can J Cardiol,2007,23(12):963-970.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部